PhaseII study of S-1/CDDP therapy for Gastric Cancer that Recurs After Adjuvant Chemotherapy with S-1.
Phase of Trial: Phase II
Latest Information Update: 03 May 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 30 Apr 2017 Status changed from active, no longer recruiting to completed.
- 13 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Oct 2012 Planned number of patients changed from 42 to 44.